BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 890660)

  • 21. [Carcinoembryonic antigen: diagnosis and tumor progression in gastrointestinal tumors].
    Brümmendorf T; Anderer FA; Staab HJ; Hornung A; Kieninger G
    Dtsch Med Wochenschr; 1985 Dec; 110(51-52):1963-8. PubMed ID: 4075992
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M; Happ J; Hottenrott C; Maul FD; Baum RP; Hör G; Encke A
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical investigation of basic fetoprotein (BFP) and carcinoembryonic antigen (CEA) in stomach cancer and lung cancer].
    Kanda Y; Ishii M
    Gan No Rinsho; 1985 May; 31(6 Suppl):600-5. PubMed ID: 2411961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study.
    Shi ZR; Tacha D; Itzkowitz SH
    J Histochem Cytochem; 1994 Sep; 42(9):1215-9. PubMed ID: 7520463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioimmunoassay of carcinoembryonic antigen in extracts of human colon and stomach.
    Martin F; Martin MS
    Int J Cancer; 1972 May; 9(3):641-7. PubMed ID: 4350129
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of colon-, lung-, and breast-derived carcinoembryonic antigen and cross-reacting antigens by monoclonal antibodies and fingerprint analysis.
    Grunert F; Luckenbach GA; Haderlie B; Schwarz K; von Kleist S
    Ann N Y Acad Sci; 1983; 417():75-85. PubMed ID: 6200051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CEA, AFP and other potential tumor markers.
    Zamcheck N; Pusztaszeri G
    CA Cancer J Clin; 1975; 25(4):204-14. PubMed ID: 48409
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue localization of zinc glycinate marker and carcinoembryonic antigen by immunofluorescence. II. Immunofluorescence microscopy.
    Doos WG; Saravis CA; Pusztaszeri G; Burke B; Oh SK; Zamcheck N; Gottlieb LS
    J Natl Cancer Inst; 1978 Jun; 60(6):1375-82. PubMed ID: 349170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence for common and distinct determinants of colon carcinoembryonic antigen, colon carcinoma antigen-III, and molecules with carcinoembryonic antigen activity isolated from breast and ovarian cancer.
    Chism SE; Warner NL; Wells JV; Crewther P; Hunt S; Marchalonis JJ; Fudenberg HH
    Cancer Res; 1977 Sep; 37(9):3100-8. PubMed ID: 69490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Roche RIA and Abbott EIA carcinoembryonic antigen assays compared.
    Fleisher M; Nisselbaum JS; Loftin L; Smith C; Schwartz MK
    Clin Chem; 1984 Feb; 30(2):200-5. PubMed ID: 6362912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Advantages and limitations of combined assays of 4 serum markers in various types of malignant neoplasms].
    Lanza E; Coda C; Ramella S; Ciambellotti E; Moro G; Cartia GL
    Minerva Med; 1986 Sep; 77(34-35):1521-5. PubMed ID: 3463886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation state specific localization of the carcino-embryonic antigen (CEA) on ultrathin cryosections of breast, stomach and lung lesions.
    Wolf B; Schwinde A; von Kleist S
    Anticancer Res; 1987; 7(2):203-8. PubMed ID: 3592632
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of elevated anti-Lewis antibodies in sera of cancer patients using a carcinoembryonic antigen-polyethylene glycol immunoassay.
    Pompecki R; Shively JE; Todd CW
    Cancer Res; 1981 May; 41(5):1910-5. PubMed ID: 6163531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carcinoembryonic antigen (CEA) monitoring in the management of radiotherapeutic patients.
    Vider M; Kashmiri R; Hunter L; Moses B; Meeker WR; Utley JF; Maruyama Y
    Oncology; 1974; 30(4):257-72. PubMed ID: 4459740
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of CEA in human gastrointestinal cancers grown in in vitro long-term organotype culture.
    Likhite VV; Wolff E
    Oncology; 1975; 32(5-6):327-32. PubMed ID: 1228545
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison between the gastrointestinal tumor antigen and the carcinoembryonic antigen in diseases of the digestive tract].
    Tappero G; Piantino P; Cerchier A; Pecchio F
    Minerva Med; 1985 Apr; 76(16):765-70. PubMed ID: 2582313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunochemical identification of carcinoembryonic antigen in ovarian adenocarcinoma and pseudomucinous cystoma extracts].
    Tatarinov IuS; Kalashnikov VV; Borisenko SA; Griaznova IM; Vasil'eva NN
    Biull Eksp Biol Med; 1975 Jan; 79(1):50-3. PubMed ID: 803383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The antigenicity of carcinoembryonic antigen in man.
    MacSween JM
    Int J Cancer; 1975 Feb; 15(2):246-52. PubMed ID: 1079205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression by human fetal organs of organ-specific cancer neoantigens as measured by leukocyte adherence inhibition.
    Gubersky M; Thomson DM; Lajzerowicz M
    Cancer Immunol Immunother; 1986; 21(2):107-13. PubMed ID: 3633212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitation and immunochemical characterization of carcinoembryonic antigen and glucose phosphate isomerase in blood and washings of patients with gastric and colonic diseases.
    Munjal D; Brady PG
    Am J Dig Dis; 1978 Jan; 23(1):57-64. PubMed ID: 619627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.